Skip to main content

Table 1 Key predictors of infections due to P. falciparum and P. vivax as detected by qPCR in 2013

From: Differential impact of malaria control interventions on P. falciparum and P. vivax infections in young Papua New Guinean children

 

P. falciparum

P. vivax

 

Observed positive (%; n = 4363)

OR

CI95

p

Observed positive (%; n = 4363)

OR

CI95

p

Areas of residence

 Ilahita 1–4, 6, 7

4.5

Reference group

6.1

Reference group

 Balanga and Balif

4.6

1.01

0.59–1.72

0.969

6.0

0.98

0.51–1.88

0.946

 Kamanokor and Ilahita 5

12.9

2.29

1.38–3.80

0.001

38.0

9.22

5.55–15.3

< 0.001

 Sunuhu 1 and 2

28.8

7.63

5.34–10.9

< 0.001

45.2

13.7

8.81–21.3

< 0.001

   

p < 0.0001a

   

p < 0.0001a

 

Age

 Linear

 

2.91

1.26–6.70

0.012

 

1.32

1.16–1.51

< 0.001

 Quadratic

 

0.88

0.78–0.99

0.032

    

ADI visit

 Enrolment

18.4

Reference group

23.2

Reference group

 Week 4

8.7

0.40

0.27–0.58

< 0.001

21.4

0.80

0.61–1.05

0.105

 Week 8

8.7

0.39

0.19–0.46

< 0.001

21.3

0.85

0.65–1.11

0.238

 Week 12

7.1

0.30

0.19–0.46

< 0.001

19.1

0.71

0.53–0.96

0.024

 Week 16

8.1

0.34

0.22–0.53

< 0.001

17.8

0.65

0.49–0.88

0.004

 Week 20

9.9

0.47

0.27–0.79

0.004

20.3

0.66

0.45–0.98

0.04

 Week 24

7.6

0.31

0.19–0.52

< 0.001

21.8

0.83

0.59–1.19

0.312

 Week 28

7.2

0.36

0.22–0.60

< 0.001

17.9

0.64

0.43–0.94

0.024

 Week 32

8.8

0.40

0.25–0.65

< 0.001

18.1

0.57

0.40–0.83

0.004

 Week 36

10.8

0.55

0.35–0.85

0.007

18.0

0.53

0.37–0.76

0.001

 Week 40

32.2

3.20

2.15–4.74

< 0.001

22.9

0.82

0.56–1.19

0.298

   

p < 0.0001a

   

p = 0.0129a

 

Haemoglobin

 

0.65

0.57–0.74

< 0.001

    

Recent antimalarial

 No

11.5

   

20.3

   

 Yes

21.3

   

15.0

0.34

0.17–0.71

0.004

Enlarged spleen

 No

10.8

   

19.2

   

 Yes

38.6

   

54.6

1.66

0.98–2.79

0.059

Febrile illness

 No

10.9

   

19.7

   

 Yes

25.0

1.84

1.30–2.62

0.001

29.2

   

b2 weeks history of febrile illness

 No

11.5

   

20.0

   

 Yes

28.6

2.24

0.93–5.38

0.073

38.1

1.84

1.02–3.32

0.042

  1. Multivariate GEE model-based estimates of risk of infection detected at each monthly active case detection visit time-point via backward selection of significant risk factors. OR multivariate adjusted odds ratio, CI95 95% confidence interval, p p value, ADI active detection of infection. aOverall significance level for the variable estimated using Wald chi-square test. bExcluding febrile illness at the time of visit